No retraction, correction or concern found when last checked on Oct 25, 2026.

Review of analytical performance of COVID-19 detection methods

Basant Giri, Shishir Pandey, Retina Shrestha and 3 more

Analytical and Bioanalytical Chemistry · 2020 · Review · CC BY

Abstract

In the recent SARS-CoV-2 pandemic, public health experts have emphasized testing, tracking infected people, and tracing their contacts as an effective strategy to reduce the spread of the virus. Several diagnostic methods are reported for detecting the coronavirus in clinical, research, and public health laboratories. Some tests detect the infection directly by detecting the viral RNA and other tests detect the infection indirectly by detecting the host antibodies. A diagnostic test during the pandemic should help make an appropriate clinical decision in a short period of time. Recently reported diagnostic methods for SARS-CoV-2 have varying throughput, batching capacity, requirement of infrastructure setting, analytical performance, and turnaround times ranging from a few minutes to several hours. These factors should be considered while selecting a reliable and rapid diagnostic method to help make an appropriate decision and prompt public health interventions. This paper reviews recent SARS-CoV-2 diagnostic methods published in journals and reports released by regulatory agencies. We compared the analytical efficiency including limit of detection, sensitivity, specificity, and throughput. In addition, we also looked into ease of use, affordability, and availability of accessories. Finally, we discuss the limitations of the methods and provide our perspectives on priorities for future test development.

References 97

1.
WHO. Coronavirus disease (COVID-19) situation reports https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed 28 Apr 2020.
Not in our library
2.
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 · 2020
No notice
3.
A new coronavirus associated with human respiratory disease in China · 2020
Corrected
4.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565-574.
Not in our library10.1016/s0140-6736(20)30251-8
5.
A pneumonia outbreak associated with a new coronavirus of probable bat origin · 2020
No notice
6.
Lam TT-Y, Shum MH-H, Zhu H-C, Tong Y-G, Ni X-B, Liao Y-S, Wei W, Cheung WY-M, Li W-J, Li F. Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins. Nature. 2020;579:1-6.
Not in our library10.1038/s41586-020-2169-0
7.
Cheng MP, Papenburg J, Desjardins M, Kanjilal S, Quach C, Libman M, et al. Diagnostic testing for severe acute respiratory syndrome–related coronavirus-2: a narrative review. Ann Intern Med. 2020. 10.7326/M20-1301.
Not in our library10.7326/m20-1301
8.
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR · 2020
Expression of concern
9.
Vogels CBF, Brito AF, Wyllie AL, et al. Analytical sensitivity and efficiency comparisons of SARS-This pre-print paper has now been published in a peer review journal. Please replace with following: CoV-2 RT–qPCR primer–probe sets. Nat Microbiol. 2020. 10.1038/s41564-020-0761-6.
Not in our library10.1038/s41564-020-0761-6
10.
Broughton JP, Deng X, Yu G, Fasching CL, Servellita V, Singh J, et al. CRISPR–Cas12-based detection of SARS-CoV-2. Nat Biotechnol. 2020. 10.1038/s41587-020-0513-4.
Not in our library10.1038/s41587-020-0513-4
11.
Hou T, Zeng W, Yang M, Chen W, Ren L, Ai J, et al. Development and evaluation of a CRISPR-based diagnostic for 2019-novel coronavirus. medRxiv. 2020. 10.1101/2020.02.22.20025460.
Not in our library
12.
Joung J, Ladha A, Saito M, Segel M, Bruneau R, Meei-li WH, et al. Point-of-care testing for COVID-19 using SHERLOCK diagnostics. medRxiv. 2020. 10.1101/2020.05.04.20091231
Not in our library
13.
Carter LJ, Garner LV, Smoot JW, Li Y, Zhou Q, Saveson CJ, Sasso JM, Gregg AC, Soares DJ, Beskid TR. Assay techniques and test development for COVID-19 diagnosis. ACS Cent Sci. 2020;6:591-605.
Not in our library10.1021/acscentsci.0c00501
14.
Green K, Graziadio S, Turner P, Fanshawe T, Allen J. Molecular and antibody point-of-care tests to support the screening, diagnosis and monitoring of COVID-19. Oxford COVID-19 Evidence Service. 2020. https://www.cebm.net/covid-19/molecular-and-antibody-point-of-care-tests-to-support-the-screening-diagnosis-and-monitoring-of-covid-19. Accessed 2 July 2020.
Not in our library
15.
Xue G, Li S, Zhang W, Du B, Cui J, Yan C, et al. A reverse-transcription recombinase-aided amplification assay for rapid detection of the 2019 novel coronavirus [SARS-CoV-2]. Anal Chem. 2020. 10.1021/acs.analchem.0c01032.
Not in our library10.1021/acs.analchem.0c01032
16.
Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 [COVID-19] in China: a report of 1014 cases. Radiology. 2020;200642. 10.1148/radiol.2020200642.
Not in our library10.1148/radiol.2020200642
17.
Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VY, Chen H, Mubareka S, Gubbay JB, Chan WC. Diagnosing COVID-19: the disease and tools for detection. ACS Nano. 2020;14:3822-3835.
Not in our library10.1021/acsnano.0c02624
18.
Qiu G, Gai Z, Tao Y, Schmitt J, Kullak-Ublick GA, Wang J. Dual-functional plasmonic photothermal biosensors for highly accurate severe acute respiratory syndrome coronavirus 2 detection. ACS Nano. 2020;14:5268-5277.
Not in our library10.1021/acsnano.0c02439
19.
Seo G, Lee G, Kim MJ, Baek S-H, Choi M, Ku KB, Lee C-S, Jun S, Park D, Kim HG. Rapid detection of COVID-19 causative virus [SARS-CoV-2] in human nasopharyngeal swab specimens using field-effect transistor-based biosensor. ACS Nano. 2020;14:5135-5142.
Not in our library10.1021/acsnano.0c02823
20.
Krüttgen A, Cornelissen CG, Dreher M, Hornef M, Imöhl M, Kleines M. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG. J Clin Virol. 2020:104394. 10.1016/j.jcv.2020.104394.
Not in our library10.1016/j.jcv.2020.104394
21.
Lassaunière R, Frische A, Harboe ZB, Nielsen AC, Fomsgaard A, Krogfelt KA, et al. Evaluation of nine commercial SARS-CoV-2 immunoassays. Medrxiv. 2020. 10.1101/2020.04.09.20056325.
Not in our library
22.
U.S. FDA. FAQs on emergency use authorizations [EUAs] for medical devices during the COVID-19 pandemic. FDA. 2020. https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-emergency-use-authorizations-euas-medical-devices-during-covid-19-pandemic. Accessed 2 July 2020.
Not in our library
23.
Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323:1843-1844.
Not in our library10.1001/jama.2020.3786
24.
Ahmed W, Angel N, Edson J, Bibby K, Bivins A, O’Brien JW, et al. First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: a proof of concept for the wastewater surveillance of COVID-19 in the community. Sci Total Environ. 2020;138764. 10.1016/j.scitotenv.2020.138764.
Not in our library10.1016/j.scitotenv.2020.138764
25.
Feng W, Newbigging A, Le C, Pang B, Peng H, Cao Y, Wu J, Abbas G, Song J, Wang D-B, Cui M, Tao J, Tyrrell DL, Zhang X-E, Zhang H, Le C. Molecular diagnosis of COVID-19: challenges and research needs. Anal Chem. 2020;92:10196-10209.
Not in our library10.1021/acs.analchem.0c02060
26.
See A, Toh ST. Respiratory sampling for severe acute respiratory syndrome coronavirus 2: an overview. Head Neck. 2020;42:1652–1656. 10.1002/hed.26232.
Not in our library10.1002/hed.26232
27.
PHLN. PHLN Guidance on laboratory testing for SARS-CoV-2 [the virus that causes COVID-19]. PHLN. 2020. https://www.health.gov.au/sites/default/files/documents/2020/02/phln-guidance-on-laboratory-testing-for-sars-cov-2-the-virus-that-causes-covid-19.pdf. Accessed 2 July 2020.
Not in our library
28.
CDC. Coronavirus disease 2019 [COVID-19] https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html. Accessed 28 Apr 2020.
Not in our library
29.
Bendavid E, Mulaney B, Sood N, Shah S, Ling E, Bromley-Dulfano R, et al. COVID-19 antibody seroprevalence in Santa Clara County, California. medRxiv. 2020. 10.1101/2020.04.14.20062463.
Not in our library10.1093/ije/dyab010
30.
WHO. Laboratory testing for coronavirus disease 2019 [COVID-19] in suspected human cases: interim guidance, 2 March 2020, World Health Organization. 2020. https://apps.who.int/iris/handle/10665/331329?show=full. Accessed 2 July 2020.
Not in our library
31.
Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, Guo Q, Song T, He J, Yen H-L, Peiris M, Wu J. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382:1177-1179.
Not in our library10.1056/nejmc2001737
32.
Wang X, Tan L, Wang X, Liu W, Lu Y, Cheng L, Sun Z. Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously. Int J Infect Dis. 2020;94:107-109.
Not in our library10.1016/j.ijid.2020.04.023
33.
Winichakoon P, Chaiwarith R, Liwsrisakun C, Salee P, Goonna A, Limsukon A, Kaewpoowat Q. Negative nasopharyngeal and oropharyngeal swabs do not rule out COVID-19. J Clin Microbiol. 2020;58(5):e00297-e00220.
Not in our library10.1128/jcm.00297-20
34.
Berenger BM, Fonseca K, Schneider AR, Hu J, Zelyas N. Sensitivity of nasopharyngeal, nasal and throat swab for the detection of SARS-CoV-2, preprint, Infectious Diseases [except HIV/AIDS]. 2020. 10.1101/2020.05.05.20084889.
Not in our library
35.
Irving SA, Vandermause MF, Shay DK, Belongia EA. Comparison of nasal and nasopharyngeal swabs for influenza detection in adults. Clin Med Res. 2012;10:215-218.
Not in our library10.3121/cmr.2012.1084
36.
OASH. Nasal [anterior nasal] specimen collection for SARS-CoV-2 diagnostic testing. https://www.cdc.gov/coronavirus/2019-ncov/downloads/OASH-nasal-specimen-collection-fact-sheet.pdf [accessed May 20, 2020].
Not in our library
37.
Mackay IM, Arden KE, Nitsche A. Real-time PCR in virology. Nucleic Acids Res. 2002;30:1292-1305.
Not in our library10.1093/nar/30.6.1292
38.
Drosten C, Seilmaier M, Corman VM, Hartmann W, Scheible G, Sack S, Guggemos W, Kallies R, Muth D, Junglen S, Müller MA, Haas W, Guberina H, Röhnisch T, Schmid-Wendtner M, Aldabbagh S, Dittmer U, Gold H, Graf P, Bonin F, Rambaut A, Wendtner C-M. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis. 2013;13:745-751.
Not in our library10.1016/s1473-3099(13)70154-3
39.
WHO. Molecular assays to diagnose COVID-19: summary table of available protocols. World Health Organization. 2020. https://www.who.int/publications/m/item/molecular-assays-to-diagnose-covid-19-summary-table-of-available-protocols. Accessed 2 July 2020.
Not in our library
40.
Analysis of the initial lot of the CDC 2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel · 2021
No notice
41.
Su S, Wong G, Shi W, Liu J, Lai AC, Zhou J, Liu W, Bi Y, Gao GF. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016;24:490-502.
Not in our library10.1016/j.tim.2016.03.003
42.
Nelson AC, Auch B, Schomaker M, Gohl DM, Grady P, Johnson D, et al. Analytical validation of a COVID-19 QRT-PCR detection assay using a 384-well format and three extraction methods. BioRxiv. 2020. 10.1101/2020.04.02.022186.
Not in our library
43.
CDC, U. Emergency use authorizations. FDA. 2020. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization. Accessed 2 July 2020.
Not in our library
44.
Chu DK, Pan Y, Cheng SM, Hui KP, Krishnan P, Liu Y, Ng DY, Wan CK, Yang P, Wang Q. Molecular diagnosis of a novel coronavirus [2019-NCoV] causing an outbreak of pneumonia. Clin Chem. 2020;66:549-555.
Not in our library10.1093/clinchem/hvaa029
45.
Comparative Performance of SARS-CoV-2 Detection Assays Using Seven Different Primer-Probe Sets and One Assay Kit · 2020
No notice
46.
Laboratory diagnosis of emerging human coronavirus infections – the state of the art · 2020
No notice
47.
Padhye NS. Reconstructed diagnostic sensitivity and specificity of 894 the RT-PCR test for COVID-19. medRxiv. 2020, 10.1101/2020.04.24.20078949
Not in our library
48.
Shirato K, Nao N, Katano H, Takayama I, Saito S, Kato F, et al. Development of genetic diagnostic methods for novel coronavirus 2019 [NCoV-2019] in Japan. Jpn J Infect Dis. 2020. 10.7883/yoken.JJID.2020.061.
Not in our library10.7883/yoken.jjid.2020.061
49.
Chan JF-W, Yip CC-Y, To KK-W, Tang TH-C, Wong SC-Y, Leung K-H, et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-PCR assay validated in vitro and with clinical specimens. J Clin Microbiol. 2020;58:e00310–20. 10.1128/JCM.00310-20.
Not in our library10.1128/jcm.00310-20
50.
Wang J, Cai K, Zhang R, He X, Shen X, Liu J, et al. A novel one-step single-tube nested quantitative real-time PCR assay for highly sensitive detection of SARS-CoV-2. Anal Chem. 2020. 10.1021/acs.analchem.0c01884.
Not in our library10.1021/acs.analchem.0c01884
51.
Mei X, Lee H-C, Diao K, Huang M, Lin B, Liu C, et al. Artificial intelligence–enabled rapid diagnosis of patients with COVID-19. Nat Med. 2020:1–5. 10.1038/s41591-020-0931-3.
Not in our library10.1038/s41591-020-0931-3
52.
Behrmann O, Bachmann I, Spiegel M, Schramm M, El Wahed AA, Dobler G, et al. Rapid detection of SARS-CoV-2 by low volume real-time single tube reverse transcription recombinase polymerase amplification using an exo probe with an internally linked quencher [Exo-IQ]. Clin Chem. 2020. 10.1093/clinchem/hvaa116.
Not in our library10.1093/clinchem/hvaa116
53.
Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2 · 2020
No notice
54.
Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, Niemeyer D, Jones TC, Vollmar P, Rothe C. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465-469.
Not in our library10.1038/s41586-020-2196-x
55.
Xiao AT, Tong YX, Zhang S. Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients. Clin Infect Dis. 2020. 10.1093/cid/ciaa460.
Not in our library10.1093/cid/ciaa460
56.
Wyllie AL, Fournier J, Casanovas-Massana A, Campbell M, Tokuyama M, Vijayakumar P, et al. Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs. medRxiv. 2020. 10.1101/2020.04.16.20067835
Not in our library
57.
Gorse GJ, Donovan MM, Patel GB. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses. J Med Virol. 2020;92:512-517.
Not in our library10.1002/jmv.25715
58.
El-Tholoth M, Bau HH, Song J. A single and two-stage, closed-tube, molecular test for the 2019 novel coronavirus [COVID-19] at home, clinic, and points of entry. ChemRxiv. 2020. 10.26434/chemrxiv.11860137.v1.
Not in our library
59.
Basu A, Zinger T, Inglima K, Woo KM, Atie O, Yurasits L, Aguero-Rosenfeld ME. Performance of Abbott ID NOW COVID-19 rapid nucleic acid amplification test in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution. Journal of Clinical Microbiology. 2020.
Not in our library10.1128/jcm.01136-20
60.
Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181-192.
Not in our library10.1038/s41579-018-0118-9
61.
Benvenuto D, Giovanetti M, Ciccozzi A, Spoto S, Angeletti S, Ciccozzi M. The 2019-new coronavirus epidemic: evidence for virus evolution. J Med Virol. 2020;92:455-459.
Not in our library10.1002/jmv.25688
62.
Diao B, Wen K, Chen J, Liu Y, Yuan Z, Han C, et al. Diagnosis of acute respiratory syndrome coronavirus 2 infection by detection of nucleocapsid protein. medRxiv. 2020. 10.1101/2020.03.07.20032524
Not in our library
63.
RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak · 2020
No notice
64.
Ai J-W, Zhang Y, Zhang H-C, Xu T, Zhang W-H. Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned. Emerg Microbes Infect. 2020;9:597-600.
Not in our library10.1080/22221751.2020.1738905
65.
Chandler-Brown D, Bueno AM, Atay O, Tsao DS. A highly scalable and rapidly deployable RNA extraction-free COVID-19 assay by quantitative sanger sequencing. bioRxiv. 2020. 10.1101/2020.04.07.029199
Not in our library
66.
Zhang F, Abudayyeh OO, Gootenberg JS. A protocol for detection of COVID-19 using CRISPR diagnostics. 2020. https://www.broadinstitute.org/files/publications/special/COVID-19 detection (updated).pdf. Accessed 2 July 2020.
Not in our library
67.
Enhancement of trans-cleavage activity of Cas12a with engineered crRNA enables amplified nucleic acid detection · 2020
Corrected
68.
ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens · 2020
No notice
69.
Dong L, Zhou J, Niu C, Wang Q, Pan Y, Sheng S, et al. Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR. medRxiv. 2020. 10.1101/2020.03.14.20036129
Not in our library10.1016/j.talanta.2020.121726
70.
Moitra P, Alafeef M, Dighe K, Frieman M, Pan D. Selective naked-eye detection of SARS-CoV-2 mediated by N gene targeted antisense oligonucleotide capped plasmonic nanoparticles. ACS Nano. 2020;14:7617-7627.
Not in our library10.1021/acsnano.0c03822
71.
Mahari S, Roberts A, Shahdeo D, Gandhi S. eCovSens-ultrasensitive novel in-house built printed circuit board based electrochemical device for rapid detection of nCovid-19 antigen, a spike protein domain 1 of SARS-CoV-2. bioRxiv. 2020.
Not in our library
72.
Janeway CA Jr, Travers P, Walport M, Shlomchik MJ. The distribution and functions of immunoglobulin isotypes. In: Immunobiology: the immune system in health and disease. 5th ed: Garland Science; 2001.
Not in our library
73.
Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020;10:102-108.
Not in our library10.1016/j.jpha.2020.03.001
74.
Stadlbauer D, Amanat F, Chromikova V, Jiang K, Strohmeier S, Arunkumar GA, Tan J, Bhavsar D, Capuano C, Kirkpatrick E. SARS-CoV-2 seroconversion in humans: a detailed protocol for a serological assay, antigen production, and test setup. Curr Protoc Microbiol. 2020;57:e100.
Not in our library10.1002/cpmc.100
75.
Cai XF, Chen J, Long QX, Deng HJ, Liu P, Fan K, Li ZJ. A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019. The Journal of Infectious Diseases. 2020. 10.1093/infdis/jiaa243.
Not in our library10.1093/infdis/jiaa243
76.
In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends · 2020
No notice
77.
To K-WT, Tsang T-YO, Leung WS, Tam AR, Wu TC, Lung DC, Yip CCY, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20:565-574.
Not in our library10.1016/s1473-3099(20)30196-1
78.
Lin D, Liu L, Zhang M, Hu Y, Yang Q, Guo J, Dai Y, et al. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak." European Journal of Clinical Microbiology & Infectious Diseases 2020;1-7. 10.1007/s10096-020-03978-6.
Not in our library10.1007/s10096-020-03978-6
79.
Zhang P, Gao Q, Wang T, Ke Y, Mo F, Jia R, et al. Evaluation of recombinant nucleocapsid and spike proteins for serological diagnosis of novel coronavirus disease 2019 [COVID-19]. MedRxiv. 2020. 10.1101/2020.03.17.20036954.
Not in our library
80.
Zhong L, Chuan J, Gong B, Shuai P, Zhou Y, Zhang Y, Jiang Z, Zhang D, Liu X, Ma S. Detection of serum IgM and IgG for COVID-19 diagnosis. Sci China Life Sci. 2020;63:777-780.
Not in our library10.1007/s11427-020-1688-9
81.
Scott A. Is a reagents shortage delaying European COVID-19 testing? https://cen.acs.org/analytical-chemistry/diagnostics/reagents-shortage-delaying-European-COVID/98/i13. Accessed 30 Apr 2020.
Not in our library
82.
Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis · 2020
No notice
83.
Xiang J, Yan M, Li H, Liu T, Lin C, Huang S, et al. Evaluation of enzyme-linked immunoassay and colloidal gold-immunochromatographic assay kit for detection of novel coronavirus [SARS-Cov-2] causing an outbreak of pneumonia [COVID-19]. medRxiv. 2020. 10.1101/2020.02.27.20028787.
Not in our library
84.
Chen Z, Zhang Z, Zhai X, Li Y, Lin L, Zhao H, Bian L, Li P, Yu L, Wu Y. Rapid and sensitive detection of anti-SARS-CoV-2 IgG using lanthanide-doped nanoparticles-based lateral flow immunoassay. Anal Chem. 2020;92:7226-7231.
Not in our library10.1021/acs.analchem.0c00784
85.
Norman M, Gilboa T, Ogata AF, Maley AM, Cohen L, Cai Y, et al. Ultra-sensitive high-resolution profiling of anti-SARS-CoV-2 antibodies for detecting early seroconversion in COVID-19 patients. medRxiv. 2020. 10.1101/2020.04.28.20083691.
Not in our library
86.
Maache M, Komurian-Pradel F, Rajoharison A, Perret M, Berland J-L, Pouzol S, Bagnaud A, Duverger B, Xu J, Osuna A. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus [SARS-CoV] nucleocapsid-based western blot assay were rectified by the use of two subunits [S1 and S2] of spike for detection of antibody to SARS-CoV. Clin Vaccine Immunol. 2006;13:409-414.
Not in our library10.1128/cvi.13.3.409-414.2006
87.
Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients · 2020
No notice
88.
Wang N, Li S-Y, Yang X-L, Huang H-M, Zhang Y-J, Guo H, Luo C-M, Miller M, Zhu G, Chmura AA. Serological evidence of bat SARS-related coronavirus infection in humans, China. Virol Sin. 2018;33:104-107.
Not in our library10.1007/s12250-018-0012-7
89.
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes · 2020
No notice
90.
WHO. Advice on the use of point-of-care immunodiagnostic tests for COVID-19. https://www.who.int/news-room/commentaries/detail/advice-on-the-use-of-point-of-care-immunodiagnostic-tests-for-covid-19. Accessed 30 Apr 2020.
Not in our library
91.
Farnsworth CW, Anderson NW. SARS-CoV-2 serology: much hype, little data. Clin Chem. 2020. 10.1093/clinchem/hvaa107.
Not in our library10.1093/clinchem/hvaa107
92.
Infantino M, Damiani A, Gobbi FL, Grossi V, Lari B, Macchia D, Casprini P, Veneziani F, Villalta D, Bizzaro N. Serological assays for SARS-CoV-2 infectious disease: benefits, limitations and perspectives. Isr Med Assoc J. 2020;22:203-210.
Not in our library
93.
Petherick A. Developing antibody tests for SARS-CoV-2. Lancet. 2020;395:1101-1102.
Not in our library10.1016/s0140-6736(20)30788-1
94.
Giri B, Pandey B, Neupane B, Ligler FS. Signal amplification strategies for microfluidic immunoassays. TrAC Trends Anal Chem. 2016;79:326-334.
Not in our library
95.
Lo S-J, Yang S-C, Yao D-J, Chen J-H, Tu W-C, Cheng C-M. Molecular-level dengue fever diagnostic devices made out of paper. Lab Chip. 2013;13:2686-2692.
Not in our library10.1039/c3lc50135c
96.
Yang T, Wang Y-C, Shen C-F, Cheng C-M. Point-of-care RNA-based diagnostic device for COVID-19. Diagnostics. 2020;10:165.
Not in our library10.3390/diagnostics10030165
97.
Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020 · 2020
No notice

Cited by papers we hold 2

Management of SARS-CoV-2 infection in pregnancy · 2021
Not checked
Factors that Influence the Reported Sensitivity of Rapid Antigen Testing for SARS-CoV-2 · 2021
Not checked

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.